Fulya Yukcu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Fulya Yukcu has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Raziye Akcılar
Department of Physiology Faculty of Medicine Kütahya Health Sciences University Kütahya Turkey
4 shared publications Nazlı Dizen Namdar
Department of Dermatology Kütahya Health Sciences University Faculty of Medicine Kütahya Türkiye
3 shared publications- Nazlı Dizen Namdar
KÜTAHYA SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, TIP FAKÜLTESİ, TIP PR
3 shared publications Raziye Akcilar
Department of Physiology, Faculty of Medicine, Kutahya Health Sciences University, Kutahya, TUR
3 shared publicationsTammam Sipahi
3 shared publications- Aycan Baş
Department of Biophysics, Faculty of Medicine Afyonkarahisar Health Sciences University Afyonkarahisar Türkiye
2 shared publications
Latest Publications
- Open Access
- 10 March 2026
- Published by Springer Nature in Cureus
- Vol. 18 (3)
Neuropeptide Y Promoter Variant rs16147 (-399 T/C) Is Associated With Susceptibility to Polycystic Ovary Syndrome
Background Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder with complex genetic and neuroendocrine underpinnings. Neuropeptide Y (NPY), a key regulator of energy balance and reproductive function, has been implicated in hypothalamic-pituitary-ovarian (HPO) axis dysregulation. However, data on variants of the NPY gene in PCOS remain limited. This study investigated the association between the NPY promoter variant rs16147 (-399 T/C) and susceptibility to PCOS. Methods In this case-control study, 102 women diagnosed with PCOS according to the Rotterdam criteria and 102 age-matched healthy controls were enrolled. Genomic DNA was extracted from peripheral blood samples, and genotyping was performed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. Demographic and anthropometric characteristics were recorded, and hormonal and metabolic parameters, including luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, thyroid-stimulating hormone (TSH), total testosterone, fasting glucose, insulin levels, lipid profile components, and homeostasis model assessment of insulin resistance (HOMA-IR), were evaluated. Genotype-phenotype associations were also explored. Results Genotype and allele distributions differed significantly between groups. The CT genotype was detected in 84 women with PCOS (82.4%) compared to 24 controls (23.5%) and was associated with increased susceptibility to PCOS (odds ratio {OR} = 15.1; 95% confidence interval {CI}: 7.65-30.0; p < 0.001). In contrast, the CC genotype was more frequent in controls (78, 76.5%) than in the PCOS group (18, 17.6%). The TT genotype was not observed in either group. Similarly, the T allele was more prevalent in women with PCOS (84, 41.2%) than in controls (24, 11.8%) (OR = 5.25; 95% CI: 3.15-8.73; p < 0.001). No significant associations were observed between rs16147 genotypes and hormonal or metabolic parameters within the PCOS cohort. Conclusions The NPY promoter variant rs16147, particularly the CT genotype and T allele, may contribute to genetic susceptibility to PCOS rather than to clinical phenotype severity. However, these findings should be interpreted with caution and require validation in larger, multicenter populations.
- 10 March 2026
- Published by Springer Nature in Cureus
- Vol. 18 (3)
Open AccessNeuropeptide Y Promoter Variant rs16147 (-399 T/C) Is Associated With Susceptibility to Polycystic Ovary Syndrome
Background Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder with complex genetic and neuroendocrine underpinnings. Neuropeptide Y (NPY), a key regulator of energy balance and reproductive function, has been implicated in hypothalamic-pituitary-ovarian (HPO) axis dysregulation. However, data on variants of the NPY gene in PCOS remain limited. This study investigated the association between the NPY promoter variant rs16147 (-399 T/C) and susceptibility to PCOS. Methods In this case-control study, 102 women diagnosed with PCOS according to the Rotterdam criteria and 102 age-matched healthy controls were enrolled. Genomic DNA was extracted from peripheral blood samples, and genotyping was performed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. Demographic and anthropometric characteristics were recorded, and hormonal and metabolic parameters, including luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, thyroid-stimulating hormone (TSH), total testosterone, fasting glucose, insulin levels, lipid profile components, and homeostasis model assessment of insulin resistance (HOMA-IR), were evaluated. Genotype-phenotype associations were also explored. Results Genotype and allele distributions differed significantly between groups. The CT genotype was detected in 84 women with PCOS (82.4%) compared to 24 controls (23.5%) and was associated with increased susceptibility to PCOS (odds ratio {OR} = 15.1; 95% confidence interval {CI}: 7.65-30.0; p < 0.001). In contrast, the CC genotype was more frequent in controls (78, 76.5%) than in the PCOS group (18, 17.6%). The TT genotype was not observed in either group. Similarly, the T allele was more prevalent in women with PCOS (84, 41.2%) than in controls (24, 11.8%) (OR = 5.25; 95% CI: 3.15-8.73; p < 0.001). No significant associations were observed between rs16147 genotypes and hormonal or metabolic parameters within the PCOS cohort. Conclusions The NPY promoter variant rs16147, particularly the CT genotype and T allele, may contribute to genetic susceptibility to PCOS rather than to clinical phenotype severity. However, these findings should be interpreted with caution and require validation in larger, multicenter populations.
- 12 February 2026
- Published by Academician Publishing
- p. 115-128
Fonksiyonel Elektrik Stimülasyonu ve Biofeedback Sistemlerinin Biyofiziksel Temelleri
Bu bölüm, fonksiyonel elektrik stimülasyonu (FES) ve biofeedback sistemlerinin nörorehabilitasyondaki rolünü biyofiziksel ve nörofizyolojik temelleriyle birlikte ele almaktadır. FES’in sinir ve kas dokularında oluşturduğu elektriksel uyarımın hücresel ve doku düzeyindeki mekanizmaları; membran potansiyel değişimleri, aksiyon potansiyeli oluşumu ve frekans-bağımlı kas yanıtları üzerinden açıklanmaktadır. Biofeedback sistemlerinin sensörimotor döngüler üzerindeki rolü ise gerçek zamanlı geri bildirim, hata-temelli motor öğrenme ve nöroplastisite bağlamında değerlendirilmektedir. Bölümde elektromiyografi (EMG), elektroensefalografi (EEG) ve hareket sensörlerine dayalı ölçüm sistemleri ile kapalı döngü FES yaklaşımlarının biyofiziksel işleyişi ve sinyal işleme prensipleri ayrıntılı olarak sunulmaktadır. EEG ve beyin-bilgisayar arayüzü (BCI) destekli FES uygulamalarının, motor niyetin doğrudan algılanmasına olanak tanıyarak istemli kas aktivitesi oluşturamayan bireylerde bile fonksiyonel hareketi mümkün kıldığı vurgulanmaktadır. Son olarak, bu bütünleşik yaklaşımların nöroplastisiteyi güçlendirme potansiyeli, klinik rehabilitasyon uygulamaları ve yapay zekâ destekli gelecek teknolojileri çerçevesinde ele alınmaktadır.
- 12 February 2026
- Published by Academician Publishing
- p. 115-128
Fonksiyonel Elektrik Stimülasyonu ve Biofeedback Sistemlerinin Biyofiziksel Temelleri
Bu bölüm, fonksiyonel elektrik stimülasyonu (FES) ve biofeedback sistemlerinin nörorehabilitasyondaki rolünü biyofiziksel ve nörofizyolojik temelleriyle birlikte ele almaktadır. FES’in sinir ve kas dokularında oluşturduğu elektriksel uyarımın hücresel ve doku düzeyindeki mekanizmaları; membran potansiyel değişimleri, aksiyon potansiyeli oluşumu ve frekans-bağımlı kas yanıtları üzerinden açıklanmaktadır. Biofeedback sistemlerinin sensörimotor döngüler üzerindeki rolü ise gerçek zamanlı geri bildirim, hata-temelli motor öğrenme ve nöroplastisite bağlamında değerlendirilmektedir. Bölümde elektromiyografi (EMG), elektroensefalografi (EEG) ve hareket sensörlerine dayalı ölçüm sistemleri ile kapalı döngü FES yaklaşımlarının biyofiziksel işleyişi ve sinyal işleme prensipleri ayrıntılı olarak sunulmaktadır. EEG ve beyin-bilgisayar arayüzü (BCI) destekli FES uygulamalarının, motor niyetin doğrudan algılanmasına olanak tanıyarak istemli kas aktivitesi oluşturamayan bireylerde bile fonksiyonel hareketi mümkün kıldığı vurgulanmaktadır. Son olarak, bu bütünleşik yaklaşımların nöroplastisiteyi güçlendirme potansiyeli, klinik rehabilitasyon uygulamaları ve yapay zekâ destekli gelecek teknolojileri çerçevesinde ele alınmaktadır.
- Open Access
- 12 February 2026
- Published by Academician Publishing
Biyofiziksel Perspektifle Fizik Tedavi Modaliteleri
- 12 February 2026
- Published by Academician Publishing
Open AccessBiyofiziksel Perspektifle Fizik Tedavi Modaliteleri
- Open Access
Investigation of Prothrombin G20210A and Factor V Leiden G1691A Variants in Patients with Acute Coronary Syndrome Presenting to the Emergency Department with Chest Pain
Background: Acute coronary syndrome (ACS) is a major cardiovascular emergency influenced by environmental and genetic factors. Thrombophilic variants such as prothrombin G20210A (rs1799963) and factor V Leiden G1691A (rs6025) may influence thrombin generation and has been reported to show associations with coronary events. Methods: This case–control study included 100 ACS patients and 131 age and sex-matched healthy controls. Genotyping of rs1799963 and rs6025 was performed using polymerase chain reaction followed by restriction fragment length polymorphism (PCR-RFLP) analysis. Results: The GG genotype was markedly more common among ACS patients for both variants. For rs1799963, carriers of the A allele (GA + AA) were less common in ACS (2.0%) than controls (9.2%; p = 0.039), corresponding to an 8.6-fold higher odds of ACS in GG carriers (OR = 8.624; 95% CI: 1.757–42.345; p = 0.008). For rs6025, A allele carriers (9.0%) were also reduced in ACS versus controls (18.3%; p = 0.049), and GG homozygotes exhibited a 2.6-fold higher risk (OR = 2.635; 95% CI: 1.104–6.290; p = 0.029). Age was independently associated with higher ACS risk (OR = 1.047; 95% CI: 1.029–1.066; p < 0.001). Conclusions: Our findings indicate that the rs1799963 and rs6025 variants were independently associated with ACS, together with advancing age. Both the GG genotype and older age were associated with higher odds of ACS, whereas A-allele carriers appeared less common among ACS cases.
Open AccessInvestigation of Prothrombin G20210A and Factor V Leiden G1691A Variants in Patients with Acute Coronary Syndrome Presenting to the Emergency Department with Chest Pain
Background: Acute coronary syndrome (ACS) is a major cardiovascular emergency influenced by environmental and genetic factors. Thrombophilic variants such as prothrombin G20210A (rs1799963) and factor V Leiden G1691A (rs6025) may influence thrombin generation and has been reported to show associations with coronary events. Methods: This case–control study included 100 ACS patients and 131 age and sex-matched healthy controls. Genotyping of rs1799963 and rs6025 was performed using polymerase chain reaction followed by restriction fragment length polymorphism (PCR-RFLP) analysis. Results: The GG genotype was markedly more common among ACS patients for both variants. For rs1799963, carriers of the A allele (GA + AA) were less common in ACS (2.0%) than controls (9.2%; p = 0.039), corresponding to an 8.6-fold higher odds of ACS in GG carriers (OR = 8.624; 95% CI: 1.757–42.345; p = 0.008). For rs6025, A allele carriers (9.0%) were also reduced in ACS versus controls (18.3%; p = 0.049), and GG homozygotes exhibited a 2.6-fold higher risk (OR = 2.635; 95% CI: 1.104–6.290; p = 0.029). Age was independently associated with higher ACS risk (OR = 1.047; 95% CI: 1.029–1.066; p < 0.001). Conclusions: Our findings indicate that the rs1799963 and rs6025 variants were independently associated with ACS, together with advancing age. Both the GG genotype and older age were associated with higher odds of ACS, whereas A-allele carriers appeared less common among ACS cases.
- 8 November 2025
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- p. 1-10
Association of the GPx-3 + 1494 A/G gene polymorphism with serum trace elements in psoriasis vulgaris
Background Psoriasis vulgaris (PV) is a chronic inflammatory skin disorder in which oxidative stress, redox imbalance, and genetic susceptibility play crucial roles. Glutathione peroxidase-3 (GPx-3), a selenium-dependent antioxidant enzyme, regulates redox homeostasis by detoxifying reactive oxygen species. Variants in the GPx-3 gene may alter antioxidant defense and trace element metabolism, thereby contributing to PV pathogenesis. Aim This case–control study investigated the association between the GPx-3 +1494A/G polymorphism and serum trace element levels in PV. Methods A total of 71 patients with PV and 71 age- and sex-matched healthy controls were genotyped using allele-specific polymerase chain reaction (AS-PCR) followed by agarose gel electrophoresis. Serum zinc (Zn), copper (Cu), and iron (Fe) concentrations were measured by atomic absorption spectrometry. Statistical analyses were performed using chi-square (χ²) and Mann–Whitney U tests. Results The AG genotype was significantly more prevalent in PV patients than in controls (88.7% vs. 50.6%, p = 0.002). Among AG carriers, PV patients exhibited higher Zn levels (p < 0.001), lower Fe concentrations (p = 0.037), and a reduced Cu/Zn ratio (p = 0.025). Additionally, the AG genotype was associated with increased body mass index (p = 0.049). Conclusion This study demonstrates a significant association between the GPx-3 +1494A/G polymorphism and serum trace element levels in PV. The AG genotype was more prevalent among patients and accompanied by elevated Zn, reduced Fe and a lower Cu/Zn ratio, suggesting genotype-related alterations in trace element balance. These findings indicate that the +1494A/G variant may contribute to psoriasis susceptibility by modulating oxidative stress and redox homeostasis.
- 8 November 2025
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- p. 1-10
Association of the GPx-3 + 1494 A/G gene polymorphism with serum trace elements in psoriasis vulgaris
Background Psoriasis vulgaris (PV) is a chronic inflammatory skin disorder in which oxidative stress, redox imbalance, and genetic susceptibility play crucial roles. Glutathione peroxidase-3 (GPx-3), a selenium-dependent antioxidant enzyme, regulates redox homeostasis by detoxifying reactive oxygen species. Variants in the GPx-3 gene may alter antioxidant defense and trace element metabolism, thereby contributing to PV pathogenesis. Aim This case–control study investigated the association between the GPx-3 +1494A/G polymorphism and serum trace element levels in PV. Methods A total of 71 patients with PV and 71 age- and sex-matched healthy controls were genotyped using allele-specific polymerase chain reaction (AS-PCR) followed by agarose gel electrophoresis. Serum zinc (Zn), copper (Cu), and iron (Fe) concentrations were measured by atomic absorption spectrometry. Statistical analyses were performed using chi-square (χ²) and Mann–Whitney U tests. Results The AG genotype was significantly more prevalent in PV patients than in controls (88.7% vs. 50.6%, p = 0.002). Among AG carriers, PV patients exhibited higher Zn levels (p < 0.001), lower Fe concentrations (p = 0.037), and a reduced Cu/Zn ratio (p = 0.025). Additionally, the AG genotype was associated with increased body mass index (p = 0.049). Conclusion This study demonstrates a significant association between the GPx-3 +1494A/G polymorphism and serum trace element levels in PV. The AG genotype was more prevalent among patients and accompanied by elevated Zn, reduced Fe and a lower Cu/Zn ratio, suggesting genotype-related alterations in trace element balance. These findings indicate that the +1494A/G variant may contribute to psoriasis susceptibility by modulating oxidative stress and redox homeostasis.
- Open Access
- 5 August 2025
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 47 (8) , 620
Analysis of Endoplasmic Reticulum Stress Proteins in Spermatogenic Cells After Paclitaxel Administration
Background/Objectives: The aim of this research is to analyze the effect of paclitaxel on endoplasmic reticulum (ER) stress in spermatogenic cells. Methods: In the study, spermatogonium (GC1) and spermatocyte (GC2) cell lines were used. The IC50 dose of paclitaxel was calculated using an MTT assay. Each cell line was separated into two different groups: control (GC1-C, GC2-C) and paclitaxel-treated (GC1-P, GC2-P). The control cells were incubated under standard culture conditions. The paclitaxel group cells were incubated in culture medium containing the paclitaxel IC50 dose for 24 h. After the experiments, all groups were stained with GRP78, p-PERK, and p-eIF2α antibodies using semi-quantitative immunocytochemistry. Results: Paclitaxel showed cytotoxicity. In the experimental model of the paclitaxel-treated cells, all the markers showed elevated levels of immunoreactivity, indicating ER stress. Conclusions: Paclitaxel administration triggered ER stress in spermatogenic cells. Studies of ER-related stress mechanisms in spermatogenic cells with further advanced molecular analyses will be important for therapeutic strategies.
- 5 August 2025
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 47 (8) , 620
Open AccessAnalysis of Endoplasmic Reticulum Stress Proteins in Spermatogenic Cells After Paclitaxel Administration
Background/Objectives: The aim of this research is to analyze the effect of paclitaxel on endoplasmic reticulum (ER) stress in spermatogenic cells. Methods: In the study, spermatogonium (GC1) and spermatocyte (GC2) cell lines were used. The IC50 dose of paclitaxel was calculated using an MTT assay. Each cell line was separated into two different groups: control (GC1-C, GC2-C) and paclitaxel-treated (GC1-P, GC2-P). The control cells were incubated under standard culture conditions. The paclitaxel group cells were incubated in culture medium containing the paclitaxel IC50 dose for 24 h. After the experiments, all groups were stained with GRP78, p-PERK, and p-eIF2α antibodies using semi-quantitative immunocytochemistry. Results: Paclitaxel showed cytotoxicity. In the experimental model of the paclitaxel-treated cells, all the markers showed elevated levels of immunoreactivity, indicating ER stress. Conclusions: Paclitaxel administration triggered ER stress in spermatogenic cells. Studies of ER-related stress mechanisms in spermatogenic cells with further advanced molecular analyses will be important for therapeutic strategies.
- Open Access
- 17 April 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (8) , 2767
Association of MTHFR and DNMT-1 Gene Polymorphisms with Acute Coronary Syndrome in Patients Admitted to the Emergency Department
Background/Objectives: Acute coronary syndrome (ACS) is a critical cardiovascular condition influenced by genetic and environmental factors. Polymorphisms in methylenetetrahydrofolate reductase (MTHFR) and deoxyribonucleic acid methyltransferase-1 (DNMT-1) genes are linked to cardiovascular diseases, yet their specific roles in ACS pathogenesis remain unclear. This study examines the association of MTHFR C677T and DNMT-1 +32204 A/G polymorphisms with ACS and their potential contribution to genetic risk profiling. Methods: A case–control study was conducted with 212 participants, including 106 ACS patients and 106 controls. Peripheral blood samples were collected and analyzed to determine genotypic and allelic frequencies using the polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) technique. Statistical analyses were performed to assess associations between gene polymorphisms and ACS risk. Results: The MTHFR C677T polymorphism showed a strong association with ACS. The CC genotype significantly increased risk (OR: 7.34; 95% CI: 2.28–23.6; p < 0.001), while the C allele was also associated with higher susceptibility (OR: 2.21; 95% CI: 1.46–3.35; p < 0.001). Conversely, the T allele exhibited a protective effect, being more frequent in controls (62.9% vs. 37.1% in ACS; p = 0.000). Elevated troponin I levels in ACS patients with the TT genotype (p = 0.025) suggested a link between MTHFR variants and disease severity. However, DNMT-1 +32204 A/G polymorphisms showed no significant association with ACS risk. Conclusions: The MTHFR C677T polymorphism influences ACS susceptibility, with the CC genotype as a risk factor and the T allele offering potential protection.
- 17 April 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (8) , 2767
Open AccessAssociation of MTHFR and DNMT-1 Gene Polymorphisms with Acute Coronary Syndrome in Patients Admitted to the Emergency Department
Background/Objectives: Acute coronary syndrome (ACS) is a critical cardiovascular condition influenced by genetic and environmental factors. Polymorphisms in methylenetetrahydrofolate reductase (MTHFR) and deoxyribonucleic acid methyltransferase-1 (DNMT-1) genes are linked to cardiovascular diseases, yet their specific roles in ACS pathogenesis remain unclear. This study examines the association of MTHFR C677T and DNMT-1 +32204 A/G polymorphisms with ACS and their potential contribution to genetic risk profiling. Methods: A case–control study was conducted with 212 participants, including 106 ACS patients and 106 controls. Peripheral blood samples were collected and analyzed to determine genotypic and allelic frequencies using the polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) technique. Statistical analyses were performed to assess associations between gene polymorphisms and ACS risk. Results: The MTHFR C677T polymorphism showed a strong association with ACS. The CC genotype significantly increased risk (OR: 7.34; 95% CI: 2.28–23.6; p < 0.001), while the C allele was also associated with higher susceptibility (OR: 2.21; 95% CI: 1.46–3.35; p < 0.001). Conversely, the T allele exhibited a protective effect, being more frequent in controls (62.9% vs. 37.1% in ACS; p = 0.000). Elevated troponin I levels in ACS patients with the TT genotype (p = 0.025) suggested a link between MTHFR variants and disease severity. However, DNMT-1 +32204 A/G polymorphisms showed no significant association with ACS risk. Conclusions: The MTHFR C677T polymorphism influences ACS susceptibility, with the CC genotype as a risk factor and the T allele offering potential protection.
- Open Access
- 1 January 2025
- Published by Kare Publishing in Journal of Clinical Practice and Research
- Vol. 47 (1) , 53-59
Investigation of Interleukin-6 -572G/C Gene Polymorphism in Vitiligo Patients
Objective: Vitiligo is a complex autoimmune condition characterized by the progressive destruction of melanocytes, resulting in patches of skin depigmentation. Interleukin-6 (IL-6), a multifunctional cytokine, has been linked to the development of various autoimmune diseases, including vitiligo. This study aims to investigate the association between the -572G/C polymorphism in the IL-6 gene and susceptibility to vitiligo. Materials and Methods: The study included 50 vitiligo patients and 50 healthy controls. Genetic analysis was conducted using DNA extracted from blood samples, followed by genotyping through polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) techniques. Results: The GG genotype was associated with a 2.53-fold increased risk of vitiligo (p=0.04, odds ratio (OR) [95% confidence interval (CI)] = 2.53 [1.03-6.23]), whereas the CG genotype significantly reduced this risk (p=0.04, OR [95% CI] = 0.39 [0.16-0.97]). A significant difference in allele frequencies was observed, with the G allele increasing the risk of vitiligo (p=0.03, OR [95% CI] = 2.39 [1.06-5.38]) and the C allele demonstrating a protective effect (p=0.03, OR [95% CI] = 0.42 [0.19-0.94]). Conclusion: The findings suggest that the GG genotype and G allele of the IL-6 -572G/C polymorphism are associated with an increased risk of vitiligo in the Turkish population, underscoring a potential role for IL-6 in the pathogenesis of the disease.
- 1 January 2025
- Published by Kare Publishing in Journal of Clinical Practice and Research
- Vol. 47 (1) , 53-59
Open AccessInvestigation of Interleukin-6 -572G/C Gene Polymorphism in Vitiligo Patients
Objective: Vitiligo is a complex autoimmune condition characterized by the progressive destruction of melanocytes, resulting in patches of skin depigmentation. Interleukin-6 (IL-6), a multifunctional cytokine, has been linked to the development of various autoimmune diseases, including vitiligo. This study aims to investigate the association between the -572G/C polymorphism in the IL-6 gene and susceptibility to vitiligo. Materials and Methods: The study included 50 vitiligo patients and 50 healthy controls. Genetic analysis was conducted using DNA extracted from blood samples, followed by genotyping through polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) techniques. Results: The GG genotype was associated with a 2.53-fold increased risk of vitiligo (p=0.04, odds ratio (OR) [95% confidence interval (CI)] = 2.53 [1.03-6.23]), whereas the CG genotype significantly reduced this risk (p=0.04, OR [95% CI] = 0.39 [0.16-0.97]). A significant difference in allele frequencies was observed, with the G allele increasing the risk of vitiligo (p=0.03, OR [95% CI] = 2.39 [1.06-5.38]) and the C allele demonstrating a protective effect (p=0.03, OR [95% CI] = 0.42 [0.19-0.94]). Conclusion: The findings suggest that the GG genotype and G allele of the IL-6 -572G/C polymorphism are associated with an increased risk of vitiligo in the Turkish population, underscoring a potential role for IL-6 in the pathogenesis of the disease.
- 1 March 2024
- Vol. 32 (1) , 1-6
Resistin Gene Promoter -420C>G (rs1862513) and +299 G>A (rs3745367) Polymorphisms in Psoriasis.
The pro-inflammatory adipokine resistin is known to be related to obesity, insulin resistance, and inflammation. Resistin's significance in the etiology of inflammatory illnesses, such as psoriasis, is explored herein. We examined the link between resistin gene polymorphisms (-420 C>G and +299 G>A) and psoriasis in the Turkish population. In this study, we examined 107 patients with psoriasis and 103 healthy controls. Resistin -420 C>G (rs1862513) and +299 G>A (rs3745367) gene polymorphisms were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). In patients with psoriasis, the frequency of the resistin -420 CG genotype was meaningfully lower than in the controls. In comparison with the controls, the resistin +299 GA genotype and A allele frequencies were significantly higher. The Resistin -420 CG genotype significantly reduced the risk of psoriasis incidence, while the resistin +299 GA genotype and A allele were found to be associated with a higher risk of psoriasis. In the Turkish community, resistin gene polymorphisms at -420 C>G and +299 G>A may exert an important influence on psoriasis etiology and susceptibility.
- 1 March 2024
- Vol. 32 (1) , 1-6
Resistin Gene Promoter -420C>G (rs1862513) and +299 G>A (rs3745367) Polymorphisms in Psoriasis.
The pro-inflammatory adipokine resistin is known to be related to obesity, insulin resistance, and inflammation. Resistin's significance in the etiology of inflammatory illnesses, such as psoriasis, is explored herein. We examined the link between resistin gene polymorphisms (-420 C>G and +299 G>A) and psoriasis in the Turkish population. In this study, we examined 107 patients with psoriasis and 103 healthy controls. Resistin -420 C>G (rs1862513) and +299 G>A (rs3745367) gene polymorphisms were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). In patients with psoriasis, the frequency of the resistin -420 CG genotype was meaningfully lower than in the controls. In comparison with the controls, the resistin +299 GA genotype and A allele frequencies were significantly higher. The Resistin -420 CG genotype significantly reduced the risk of psoriasis incidence, while the resistin +299 GA genotype and A allele were found to be associated with a higher risk of psoriasis. In the Turkish community, resistin gene polymorphisms at -420 C>G and +299 G>A may exert an important influence on psoriasis etiology and susceptibility.
- 1 January 2024
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 46 (5)
Investigation of Vaspin and Visfatin -4689G/T Gene Polymorphisms in Alopecia Areata Patients
Alopecia Areata (AA) is a chronic autoimmune condition that causes recurrent hair bereavement. Genetic and immunological factors act a part in the pathogenesis of AA. The aim of this study was to look into relationship between the vaspin and visfatin -4689G/T gene polymorphisms and AA sensibility in the Turkish population. This study included 80 AA patients and 80 healthy controls. Genomic DNA was extracted of blood samples Vaspin and visfatin -4689G/T gene polymorphisms were determined using polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) methods. The observed disparity in vaspin genotypes and allele distribution amid AA patients and healthy controls did not reach statistical significance (χ2 = 2.51, df = 1, p = 0.11 and χ2 = 1.75, df = 1, p = 0.18, respectively). Although visfatin GT genotype was higher in AA patients compared to control, it was not statistically significant. People with the visfatin GT genotype were more likely to be AA than people with the GG genotype [OR (95% CI) = 2.11 (1.04-4.27), p = 0.03]. This study shows that there is no affair amid vaspin and visfatin -4689G/T polymorphism and AA in the Turkish population. However, the TT genotype for the vaspin gene and the GT genotype for the visfatin -4689G/T gene are risk factors for people with AA disease.
- 1 January 2024
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 46 (5)
Investigation of Vaspin and Visfatin -4689G/T Gene Polymorphisms in Alopecia Areata Patients
Alopecia Areata (AA) is a chronic autoimmune condition that causes recurrent hair bereavement. Genetic and immunological factors act a part in the pathogenesis of AA. The aim of this study was to look into relationship between the vaspin and visfatin -4689G/T gene polymorphisms and AA sensibility in the Turkish population. This study included 80 AA patients and 80 healthy controls. Genomic DNA was extracted of blood samples Vaspin and visfatin -4689G/T gene polymorphisms were determined using polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) methods. The observed disparity in vaspin genotypes and allele distribution amid AA patients and healthy controls did not reach statistical significance (χ2 = 2.51, df = 1, p = 0.11 and χ2 = 1.75, df = 1, p = 0.18, respectively). Although visfatin GT genotype was higher in AA patients compared to control, it was not statistically significant. People with the visfatin GT genotype were more likely to be AA than people with the GG genotype [OR (95% CI) = 2.11 (1.04-4.27), p = 0.03]. This study shows that there is no affair amid vaspin and visfatin -4689G/T polymorphism and AA in the Turkish population. However, the TT genotype for the vaspin gene and the GT genotype for the visfatin -4689G/T gene are risk factors for people with AA disease.